Skip to main content
DC 6602Respiratory System

Secondary Conditions for Bronchial Asthma

3 conditions have documented medical links to Bronchial Asthma. These may qualify as secondary service-connected disabilities if you can establish a medical nexus.

Evidence Strength:STRONGMODERATEEMERGING
MODERATE

Medical Rationale

Burn pit combustion products — a complex mixture of fine particulate matter (PM2.5), volatile organic compounds (benzene, toluene), dioxins, polyaromatic hydrocarbons, and heavy metals — produce chronic upper respiratory inflammation through direct mucosal toxicity and immune sensitization. Inhaled particles deposit in the nasal and sinus mucosa, triggering persistent innate immune activation, mucociliary clearance dysfunction, and biofilm formation by opportunistic bacteria in the inflamed mucosa. Sinus ostial inflammation causes obstruction of mucociliary drainage, creating the anatomical conditions for chronic sinusitis: blocked drainage, bacterial/fungal colonization, and persistent mucosal edema. Clinical studies of OEF/OIF veterans with documented burn pit exposure document chronic rhinosinusitis rates 2–3 times higher than non-deployed veteran controls. The PACT Act (2022) expanded presumptive service connection for many airborne hazard conditions.

Key Studies

Sharkey JM et al. (2012) J Occup Environ Med (airborne hazards and respiratory conditions); Abraham JH et al. (2012) Occup Environ Med (deployment exposures and respiratory health); Baird CP et al. (2012) J Occup Environ Med; Lucchini RG et al. (2012) Am J Ind Med.

Filing Tips

CT scan of the paranasal sinuses documenting mucosal thickening, polyps, or air-fluid levels. ENT records documenting chronic sinusitis diagnosis, endoscopy findings, and treatment (antibiotics, nasal steroids, FESS surgery). Deployment records confirming service in OEF/OIF/OND theater with burn pit or airborne hazard exposure. Under the PACT Act, many respiratory conditions in veterans who served in covered locations after August 2, 1990 are now presumptively service-connected — check if your sinusitis qualifies before filing as secondary. File secondary sleep disturbance from nasal obstruction if chronic sinusitis is impairing sleep.

MODERATE

Medical Rationale

Vocal cord dysfunction (VCD), or paradoxical vocal fold motion (PVFM), develops in 19-50% of patients with difficult-to-control asthma. The mechanism involves laryngeal hyperresponsiveness triggered by chronic airway inflammation — inflammatory mediators from the lower airways sensitize vagal afferent C-fibers in the laryngeal mucosa, producing reflexive paradoxical adduction of the vocal folds during inspiration. Additionally, chronic cough from poorly controlled asthma causes mechanical trauma to the vocal folds, producing edema and contact granulomas that alter airflow dynamics and promote abnormal fold motion. Gastroesophageal reflux, highly prevalent in asthma patients, further irritates the posterior larynx and exacerbates VCD. VCD presents with inspiratory stridor, throat tightness, and dyspnea that is frequently misdiagnosed as refractory asthma.

Key Studies

Newman KB et al. (1995) Am J Respir Crit Care Med (VCD in asthma patients — clinical features); Morris MJ et al. (2006) Respir Med (vocal cord dysfunction in military populations — prevalence and diagnosis).

Filing Tips

Laryngoscopy during a symptomatic episode documenting paradoxical vocal fold adduction during inspiration (gold standard diagnosis). Pulmonary function testing with inspiratory flow-volume loop showing truncated inspiratory limb. Speech-language pathology evaluation. Pulmonology or ENT nexus letter addressing the laryngeal hyperresponsiveness mechanism linking asthma to VCD. Note the Morris et al. (2006) study specifically documenting VCD prevalence in military populations. File under DC 6516 (laryngitis, chronic) or consider under respiratory disability.

STRONG

Medical Rationale

Asthma and GERD have a bidirectional, well-established comorbid relationship with multiple reinforcing mechanisms. Acid reflux exacerbates asthma through vagally-mediated bronchospasm triggered by esophageal acid exposure (esophago-bronchial reflex), microaspiration of acid droplets causing direct airway mucosal inflammation, and activation of esophageal afferents that enhance bronchial reactivity. Conversely, asthma promotes GERD: (1) hyperinflation from air trapping increases intraabdominal-to-intrathoracic pressure gradient, reducing lower esophageal sphincter effectiveness; (2) bronchodilators used for asthma treatment (theophylline, beta-2 agonists) relax the lower esophageal sphincter; (3) oral corticosteroids increase gastric acid secretion. Studies document GERD in 34–89% of asthmatic patients. Clinical trials show that GERD treatment improves nocturnal asthma control, confirming the causal pathway from GERD to asthma worsening and vice versa.

Key Studies

Harding SM & Richter JE (1997) Ann Intern Med (GERD-asthma mechanisms); Sontag SJ et al. (1999) Gastroenterology (GERD and asthma therapy); Havemann BD et al. (2007) Gut (meta-analysis of GERD and asthma); Field SK (1999) Can Respir J.

Filing Tips

Pulmonary function test (PFT) records documenting asthma severity. Upper endoscopy or pH monitoring documenting GERD. A gastroenterology or pulmonology nexus letter addressing the LES relaxation from bronchodilator therapy and the hyperinflation mechanism. If asthma is the service-connected primary condition, GERD can be filed as secondary with straightforward medical evidence. Include records of specific bronchodilator prescriptions in the claim package.

← Back to Bronchial Asthma rating criteria

Find All Secondary Conditions for Your Situation

AIDEN can analyze your complete medical history and identify secondary conditions specific to your case, including connections that may not appear in standard databases.

Discover Your Secondary Conditions